Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Jan Kullberg

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|October 27, 2022
[Conflicts of interest in scientific advisory panels]Bart-Jan Kullberg, Marianne Geleijnse
Cell Host & Microbe|September 14, 2010
Epithelial sensing of fungal invasionMihai G Netea, Bart Jan Kullberg
The New England Journal of Medicine|March 3, 2016
Invasive CandidiasisBart Jan Kullberg, Maiken C Arendrup
The New England Journal of Medicine|October 8, 2015
Invasive CandidiasisBart Jan Kullberg, Maiken C Arendrup
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Patient Susceptibility to Candidiasis-A Potential for Adjunctive ImmunotherapyLinda Davidson, Mihai G Netea, Bart Jan Kullberg
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Phagocytosis and intracellular killing of Candida albicans by murine polymorphonuclear neutrophilsAlieke G Vonk, Mihai G Netea, Bart Jan Kullberg
The Journal of Infection|October 3, 2015
Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disordersJaap ten Oever, Mihai G Netea, Bart-Jan Kullberg
The Journal of Antimicrobial Chemotherapy|April 18, 2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and commentsJanos Sinkó, Bart Jan Kullberg, John E Edwards, et al.
Current Opinion in Infectious Diseases|October 12, 2014
Immunotherapy: a potential adjunctive treatment for fungal infectionBart-Jan Kullberg, Frank van de Veerdonk, Mihai G Netea
Medical Mycology|August 20, 2010
ICU-acquired immunosuppression and the risk for secondary fungal infectionsGuillaume Monneret, Fabienne Venet, Bart-Jan Kullberg, et al.
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Nederlands Tijdschrift Voor Geneeskunde|October 27, 2022
[Conflicts of interest in scientific advisory panels]Bart-Jan Kullberg, Marianne Geleijnse
Cell Host & Microbe|September 14, 2010
Epithelial sensing of fungal invasionMihai G Netea, Bart Jan Kullberg
The New England Journal of Medicine|March 3, 2016
Invasive CandidiasisBart Jan Kullberg, Maiken C Arendrup
The New England Journal of Medicine|October 8, 2015
Invasive CandidiasisBart Jan Kullberg, Maiken C Arendrup
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Patient Susceptibility to Candidiasis-A Potential for Adjunctive ImmunotherapyLinda Davidson, Mihai G Netea, Bart Jan Kullberg
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Phagocytosis and intracellular killing of Candida albicans by murine polymorphonuclear neutrophilsAlieke G Vonk, Mihai G Netea, Bart Jan Kullberg
The Journal of Infection|October 3, 2015
Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disordersJaap ten Oever, Mihai G Netea, Bart-Jan Kullberg
The Journal of Antimicrobial Chemotherapy|April 18, 2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and commentsJanos Sinkó, Bart Jan Kullberg, John E Edwards, et al.
Current Opinion in Infectious Diseases|October 12, 2014
Immunotherapy: a potential adjunctive treatment for fungal infectionBart-Jan Kullberg, Frank van de Veerdonk, Mihai G Netea
Medical Mycology|August 20, 2010
ICU-acquired immunosuppression and the risk for secondary fungal infectionsGuillaume Monneret, Fabienne Venet, Bart-Jan Kullberg, et al.
Pageof 26